Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase 1/2 2Phase 2 1Phase 1 1

Status

Unknown 2Recruiting 2Withdrawn 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 63Breast 46Thoracic 44Gynecologic 34Genitourinary 28Tumor-Agnostic 25Other hematologic neoplasm 24Lymphoid 23Head & Neck 21CNS 21Dermatologic 16Sarcoma 12Plasma cell 9Myeloid 5Other solid neoplasm 3NET 1Endocrine 1Classical hematology 1

Conditions

Myelodysplastic Syndromes 3Myeloproliferative Disorders 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1COVID-19 1

Interventions

Cyclophosphamide 21fludarabine phosphate 15Cyclosporine 13Antilymphocyte Serum 13Peripheral Blood Stem Cell Transplantation 12Busulfan 12Whole-Body Irradiation 11Mycophenolic Acid 10Filgrastim 8fludarabine 7Methotrexate 7Melphalan 7Therapeutics 5Radiotherapy 5Cytarabine 5Blood Specimen Collection 5Tacrolimus 4Psychiatric Rehabilitation 4Methylprednisolone 4Cord Blood Stem Cell Transplantation 4thymoglobulin 3Stem Cell Transplantation 3Palliative Care 3Imatinib Mesylate 3Granulocyte Colony-Stimulating Factor 3Flow Cytometry 3Dexamethasone 3Behavior Therapy 3Aprepitant 3sargramostim 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase NA × Blood Specimen Collection × Myeloid × Clear all
NCT04953312 2026-03-12

CALPRO

Assistance Publique - Hôpitaux de Paris

Phase NA Withdrawn
MyeloidOther hematologic neoplasm

COVID-19, Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic

NCT05983991 2025-12-26

GATA-2

Institut Claudius Regaud

Phase NA Recruiting
150 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT06130787 2024-09-27

BIO-TIMER

University Hospital, Clermont-Ferrand

Phase NA Recruiting
321 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT05714592 2023-02-22

MYELOCARTOCH

Centre Hospitalier Universitaire, Amiens

Phase NA Unknown
300 enrolled
Myeloid

Myeloproliferative Disorders

NCT02489929 2015-07-03

Evaluation of Cytidine Deaminase for Patient Suffering of a Myelodysplastic Syndrom or an AML Treated by Azacytidine

Assistance Publique Hopitaux De Marseille

Phase NA Unknown
35 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myeloid, Myelodysplastic Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡